Similar Search Results

Demand systems and the true subindex of the cost of living for pharmaceuticals

Baye, Michael R. - In: Applied economics 29 (1997) 9, pp. 1179-1189

Persistent link: https://www.econbiz.de/10001227186

Demand for prescription drugs under non-linear pricing in Medicare Part D

Jung, Kyoungrae; Feldman, Roger D.; McBean, A. Marshall - In: International journal of health care finance and economics 14 (2014) 1, pp. 19-40

Persistent link: https://www.econbiz.de/10010343511

The Rand Health Insurance Experiment, Three Decades Later

Aron-Dine, Aviva - 2012

We re-present and re-examine the analysis from the famous RAND Health Insurance Experiment from the 1970s on the impact of consumer cost sharing in health insurance on medical spending. We begin by summarizing the experiment and its core findings in a manner that would be standard in the current...

Persistent link: https://www.econbiz.de/10013096134

Prescription Drug Use Under Medicare Part D : A Linear Model of Nonlinear Budget Sets

Abaluck, Jason - 2015

Medicare Part D enrollees face a complicated decision problem: they must dynamically choose prescription drug consumption in each period given difficult- to-find prices and a non-linear budget set. We use Medicare Part D claims data from 2006-2009 to estimate a flexible model of consumption that...

Persistent link: https://www.econbiz.de/10013027269

Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting

Yeung, Kai - 2016

pharmaceuticals, are deemed to be price inelastic with price elasticities of demand (PED) close to -0.20. However, most studies of PED … designed based on drug-specific incremental cost-effectiveness ratios, we estimate price elasticities of pharmaceuticals within … produce positive welfare effects. We estimate an overall PED for pharmaceuticals to be -0.16, close to the estimate of RAND …

Persistent link: https://www.econbiz.de/10012989727

Private Provision of Social Insurance : Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D

Einav, Liran - 2016

Standard theory suggests that optimal consumer cost-sharing in health insurance increases with the price elasticity of demand, yet publicly-provided drug coverage typically involves uniform cost-sharing across drugs. We investigate how private drug plans set cost-sharing in the context of...

Persistent link: https://www.econbiz.de/10012991674

Heterogeneity in Cost-Sharing and Cost-Sensitivity, and the Role of the Prescribing Physician

Carrera, Mariana; Goldman, Dana; Goldman, Dana P.; … - 2021

In this paper, we use individual level data on purchases of one of the most prescribed categories of drugs (cholesterol-lowering statins) to study the responses of physicians and patients to variation in the cost of drugs. In a sample of first-time statin prescriptions to employees from a group...

Persistent link: https://www.econbiz.de/10013225005

Price Sensitivity of Demand for Prescription Drugs : Exploiting a Regression Kink Design

Simonsen, Marianne - 2010

This paper investigates price sensitivity of demand for prescription drugs using drug purchase records for at 20% random sample of the Danish population. We identify price responsiveness by exploiting exogenous variation in prices caused by kinked reimbursement schemes and implement a regression...

Persistent link: https://www.econbiz.de/10013148927

On the demand for prescription drugs : heterogeneity in price responses

Skipper, Niels - In: Health economics 22 (2013) 7, pp. 857-869

Persistent link: https://www.econbiz.de/10009780267

The impact of pricing and patent expiration on the demand for pharmaceuticals : an examination of the use of broad-spectrum antimicrobials

Kaier, Klaus - 2010

The aim of the analysis was to determine whether demand in Germany for antibiotics is driven by prices that drop considerably when generic substitutes become available. A time-series approach was therefore carried out to explore price elasticities of demand for two different classes of...

Persistent link: https://www.econbiz.de/10009127962